Table 2.
Patient characteristics comparing the patients who had neutrophil to lymphocyte ratio (NLR) more than 3 to those with NLR equal or less than 3.
| NLR > 3 | NLR ≤ 3 | ||
| Characteristics | N = 169 | N = 294 | P value |
| Age: Mean (SD) | 51 (13) | 51 (11) | .47 |
| Gender: Men | 113 (67%) | 213 (72%) | .21 |
| Women | 56 (33%) | 81 (28%) | |
| BMI: < 18.5 | 33 (20%) | 16 (5%) | <.001 |
| 18.5 to 22.9 | 92 (54%) | 173 (59%) | |
| 23 to 24.9 | 35 (21%) | 84 (29%) | |
| ≥ 25 | 9 (5%) | 21 (7%) | |
| WHO classification: Type I | 4 (2%) | 2 (1%) | .206 |
| Type II | 63 (37%) | 99 (34%) | |
| Type III | 102 (61%) | 193 (65%) | |
| T stage: T1 | 22 (13%) | 43 (15%) | .005 |
| T2 | 40 (24%) | 113 (38%) | |
| T3 | 50 (30%) | 64 (22%) | |
| T4 | 57 (34%) | 74 (25%) | |
| N stage: N0 | 12 (7%) | 28 (10%) | .72 |
| N1 | 52 (31%) | 96 (33%) | |
| N2 | 58 (34%) | 98 (33%) | |
| N3 | 47 (28%) | 72 (24%) | |
| AJCC staging: I | 2 (1%) | 5 (2%) | .043 |
| II | 20 (12%) | 64 (22%) | |
| III | 55 (33%) | 90 (30%) | |
| IVA | 92 (54%) | 135 (46%) | |
| NLR: Mean (SD) | 5.3 (2.8) | 2.0 (0.6) | <.001 |
| Median (IQR) | 4.2 (3.5–6.4) | 2.0 (1.6–2.5) | <.001 |
IQR = interquartile range, SD = standard deviation.